Impact of single checkpoint inhibitors and biomarkers of response

被引：0
|
作者：
El-Khoueiry, Anthony [1 ]
机构：
[1] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
来源：
CLINICAL CANCER RESEARCH | 2022年 / 28卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA16
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Biomarkers for predicting the efficacy of immune checkpoint inhibitors
    Wang, Chengji
    Wang, He-nan
    Wang, Liang
    JOURNAL OF CANCER, 2022, 13 (02): : 481 - 495
  • [32] Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy
    Min Zhang
    Jingwen Yang
    Wenjing Hua
    Zhong Li
    Zenghui Xu
    Qijun Qian
    Frontiers of Medicine, 2019, 13 : 32 - 44
  • [33] Biomarkers related to immune checkpoint inhibitors therapy
    Li, Na
    Hou, Xin
    Huang, Shaogang
    Tai, Risheng
    Lei, Lei
    Li, Siyu
    Abuliz, Adina
    Wang, Geng
    Yang, Shanru
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [34] Biomarkers for immune checkpoint inhibitors in solid tumors
    Kapoor, Vidit
    Kelly, William James
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 126 - 136
  • [35] Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy
    Zhang, Min
    Yang, Jingwen
    Hua, Wenjing
    Li, Zhong
    Xu, Zenghui
    Qian, Qijun
    FRONTIERS OF MEDICINE, 2019, 13 (01) : 32 - 44
  • [36] Advances and prospects of biomarkers for immune checkpoint inhibitors
    Yamaguchi, Hirohito
    Hsu, Jung-Mao
    Sun, Linlin
    Wang, Shao-Chun
    Hung, Mien-Chie
    CELL REPORTS MEDICINE, 2024, 5 (07)
  • [37] Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
    Sholl, Lynette M.
    MODERN PATHOLOGY, 2022, 35 (SUPPL 1) : 66 - 74
  • [38] Biomarkers for evaluating the clinical response to immune checkpoint inhibitors in renal cell carcinoma (Review)
    Gonzalez-Garza, Raquel
    Gutierrez-Gonzalez, Adrian
    Salinas-Carmona, Mario Cesar
    Mejia-Torres, Manuel
    ONCOLOGY REPORTS, 2024, 52 (06)
  • [39] Biomarkers for immune checkpoint inhibitors in solid tumors
    Vidit Kapoor
    William James Kelly
    Clinical and Translational Oncology, 2023, 25 : 126 - 136
  • [40] SPATIAL PROTEOMIC AND TRANSCRIPTOMIC BIOMARKERS OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN OPERABLE LUNG CANCER
    Stauber, Jonathan
    Ramos, Corinne
    Ponzoni, Adele
    Gerstenberg, Amandine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A552 - A552
12345